Fonarow GC, Abraham WT, Gheorghiade M, Cannon CP, Sackner-Bernstein JD, Udelson JE, Konstam MA; Postmyocardial Infarction Consensus Guideline Committee. Role of beta-blocker therapy in the postmyocardial infarction patient with and without left ventricular dysfunction consensus guideline. Crit Pathw Cardiol. 2003 Dec;2(4):239-46. doi: 10.1097/01.hpc.0000099743.53432.a8.
Cannon CP, Braunwald E; STRIVE Scientific Council. Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) acute coronary syndromes Critical Pathway Toolkit. Crit Pathw Cardiol. 2003 Sep;2(3):153-77. doi: 10.1097/01.hpc.0000085366.42909.60.
Kelly-Hayes M, Beiser A, Kase CS, Scaramucci A, D’Agostino RB, Wolf PA. The influence of gender and age on disability following ischemic stroke: the Framingham study. J Stroke Cerebrovasc Dis. 2003 May-Jun;12(3):119-26. doi: 10.1016/S1052-3057(03)00042-9.
Dumaine R, Bigelow B, Aroesty J, Gibson CM. Myocardial reperfusion: its assessment and its relation to clinical outcomes. Am Heart Hosp J. 2003 Spring;1(2):120-7. doi: 10.1111/j.1541-9215.2003.02348.x.
Cannon CP. Treatment algorithms and critical pathways for acute coronary syndromes. Semin Vasc Med. 2003 Nov;3(4):425-32. doi: 10.1055/s-2004-817692.
Hobbach HP, Gibson CM, Giugliano RP, Hundertmark J, Schaeffer C, Tscherleniak W, Schuster P. The prognostic value of serum creatinine on admission in fibrinolytic-eligible patients with acute myocardial infarction. J Thromb Thrombolysis. 2003 Dec;16(3):167-74. doi: 10.1023/B:THRO.0000024055.13207.50.
Cannon CP. The next step in cardiovascular protection. Atheroscler Suppl. 2003 Dec;4(5):3-9. doi: 10.1016/s1567-5688(03)90001-8.
Gibson CM, Kirtane AJ, Murphy SA, Karha J, Cannon CP, Giugliano RP, Roe MT, Harrington RA, Ohman EM, Antman EM. Distance from the coronary ostium to the culprit lesion in acute ST-elevation myocardial infarction and its implications regarding the potential prevention of proximal plaque rupture. J Thromb Thrombolysis. 2003 Jun;15(3):189-96. doi: 10.1023/B:THRO.0000011374.60110.bc.
Krob AH, Fleischer AB Jr, D’Agostino R Jr, Feldman SR. Terbinafine is more effective than itraconazole in treating toenail onychomycosis: results from a meta-analysis of randomized controlled trials. J Cutan Med Surg. 2003 Jul-Aug;7(4):306-11. doi: 10.1007/s10227-002-0139-9.
Kathiresan S, MacGillivray TE, Lewandrowski K, Servoss SJ, Lewandrowski E, Januzzi JL Jr. Off-pump coronary bypass grafting is associated with less myocardial injury than coronary bypass surgery with cardiopulmonary bypass. Heart Surg Forum. 2003;6(6):E174-8.
Irwin ME, Bainey KR, Senaratne MP. Evaluation of the appropriateness of pacemaker mode selection in bradycardia pacing: how closely are the ACC/AHA guidelines followed?. Pacing Clin Electrophysiol. 2003 Dec;26(12):2301-7. doi: 10.1111/j.1540-8159.2003.00363.x.
Stone GW, Cox DA, Babb J, Nukta D, Bilodeau L, Cannon L, Stuckey TD, Hermiller J, Cohen EA, Low R, Bailey SR, Lansky AJ, Kuntz RE. Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries. J Am Coll Cardiol. 2003 Dec 3;42(11):2007-13. doi: 10.1016/j.jacc.2003.10.001.
Cutlip DE, Ho KK, Kuntz RE, Baim DS. Risk assessment for percutaneous coronary intervention: our version of the weather report?. J Am Coll Cardiol. 2003 Dec 3;42(11):1896-9. doi: 10.1016/j.jacc.2003.09.008.
Budaj A, Brieger D, Steg PG, Goodman SG, Dabbous OH, Fox KA, Avezum A, Cannon CP, Mazurek T, Flather MD, Van De Werf F; GRACE Investigators. Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). Am Heart J. 2003 Dec;146(6):999-1006. doi: 10.1016/S0002-8703(03)00509-X.
Sosnovik DE, Januzzi JL, Church CC, Mertsch JA, Sears AL, Fetterman RC, Walovitch RC, Picard MH. Measurement of radial artery contrast intensity to assess cardiac microbubble behavior. J Am Soc Echocardiogr. 2003 Dec;16(12):1267-73. doi: 10.1067/j.echo.2003.08.009.
Cannon CP, Eckardt JJ, Kabo JM, Ward WG Sr, Kelly CM, Wirganowicz PZ, Asavamongkolkul A, Nieves R, Eilber FR. Custom cross-pin fixation of 32 tumor endoprostheses stems. Clin Orthop Relat Res. 2003 Dec;(417):285-92. doi: 10.1097/01.blo.0000096801.78689.9e.
Vogel TU, Reynolds MR, Fuller DH, Vielhuber K, Shipley T, Fuller JT, Kunstman KJ, Sutter G, Marthas ML, Erfle V, Wolinsky SM, Wang C, Allison DB, Rud EW, Wilson N, Montefiori D, Altman JD, Watkins DI. Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239. J Virol. 2003 Dec;77(24):13348-60. doi: 10.1128/jvi.77.24.13348-13360.2003.
Etges A, Pinto DS Jr, Kowalski LP, Soares FA, Araújo VC. Salivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumour. J Clin Pathol. 2003 Dec;56(12):914-8. doi: 10.1136/jcp.56.12.914.
Scott NS, King ME, McQuillan B, Shariff S, Hung JW, Januzzi JL, Palacios IF, Picard MH. Effect of atrial septal mobility on transcatheter closure of interatrial communications. Echocardiography. 2003 Nov;20(8):711-4. doi: 10.1111/j.0742-2822.2003.02173.x.
Yeh RW, Gerson LB, Triadafilopoulos G. Efficacy of esomeprazole in controlling reflux symptoms, intraesophageal, and intragastric pH in patients with Barrett’s esophagus. Dis Esophagus. 2003;16(3):193-8. doi: 10.1046/j.1442-2050.2003.00327.x.
Gibson CM, Pinto DS, Murphy SA, Morrow DA, Hobbach HP, Wiviott SD, Giugliano RP, Cannon CP, Antman EM, Braunwald E; TIMI Study Group. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol. 2003 Nov 5;42(9):1535-43. doi: 10.1016/j.jacc.2003.06.001.
Eckardt JJ, Kabo JM, Kelly CM, Ward WG Sr, Cannon CP. Endoprosthetic reconstructions for bone metastases. Clin Orthop Relat Res. 2003 Oct;(415 Suppl):S254-62. doi: 10.1097/01.blo.0000093044.56370.94.
Januzzi JL, Cannon CP, Theroux P, Boden WE. Optimizing glycoprotein IIb/IIIa receptor antagonist use for the non-ST-segment elevation acute coronary syndromes: risk stratification and therapeutic intervention. Am Heart J. 2003 Nov;146(5):764-74. doi: 10.1016/S0002-8703(03)00437-X.
Stone PH, Coskun AU, Yeghiazarians Y, Kinlay S, Popma JJ, Kuntz RE, Feldman CL. Prediction of sites of coronary atherosclerosis progression: In vivo profiling of endothelial shear stress, lumen, and outer vessel wall characteristics to predict vascular behavior. Curr Opin Cardiol. 2003 Nov;18(6):458-70. doi: 10.1097/00001573-200311000-00007.
Sundström J, Sullivan L, D’Agostino RB, Jacques PF, Selhub J, Rosenberg IH, Wilson PW, Levy D, Vasan RS. Plasma homocysteine, hypertension incidence, and blood pressure tracking: the Framingham Heart Study. Hypertension. 2003 Dec;42(6):1100-5. doi: 10.1161/01.HYP.0000101690.58391.13. Epub 2003 Nov 3.
McCall WV, D’Agostino R Jr, Dunn A. A meta-analysis of sleep changes associated with placebo in hypnotic clinical trials. Sleep Med. 2003 Jan;4(1):57-62. doi: 10.1016/s1389-9457(02)00242-3.
Hennekens CH, D’Agostino RB. Global risk assessment for cardiovascular disease and astute clinical judgement. Eur Heart J. 2003 Nov;24(21):1899-900. doi: 10.1016/j.ehj.2003.08.012.
Fonarow GC, Abraham WT, Cannon CP, Gheorghiade M, Sackner-Bernstein JD, Udelson JE; Post-Myocardial Infarction Guideline Committee. Role of beta-blocker therapy in the post-myocardial infarction patient with and without left ventricular dysfunction. Rev Cardiovasc Med. 2003;4 Suppl 3:S54-9.
Williams K, Sniderman AD, Sattar N, D’Agostino R Jr, Wagenknecht LE, Haffner SM. Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2003 Nov 11;108(19):2312-6. doi: 10.1161/01.CIR.0000097113.11419.9E. Epub 2003 Oct 27.
Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox KA; Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003 Oct 27;163(19):2345-53. doi: 10.1001/archinte.163.19.2345.
Waksman R, Raizner A, Popma JJ. Beta emitter systems and results from clinical trials. state of the art. Cardiovasc Radiat Med. 2003 Apr-Jun;4(2):54-63. doi: 10.1016/s1522-1865(03)00169-0.
Shah PB, Cutlip DE, Popma JJ, Kuntz RE, Ho KK. Incidence and predictors of late total occlusion following coronary stenting. Catheter Cardiovasc Interv. 2003 Nov;60(3):344-51. doi: 10.1002/ccd.10665.
Vasan RS, Sullivan LM, D’Agostino RB, Roubenoff R, Harris T, Sawyer DB, Levy D, Wilson PW. Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann Intern Med. 2003 Oct 21;139(8):642-8. doi: 10.7326/0003-4819-139-8-200310210-00007.
Baim DS. Percutaneous treatment of saphenous vein graft disease: the ongoing challenge. J Am Coll Cardiol. 2003 Oct 15;42(8):1370-2. doi: 10.1016/s0735-1097(03)01039-8.
Roubenoff R, Parise H, Payette HA, Abad LW, D’Agostino R, Jacques PF, Wilson PW, Dinarello CA, Harris TB. Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am J Med. 2003 Oct 15;115(6):429-35. doi: 10.1016/j.amjmed.2003.05.001.
Moscucci M, Fox KA, Cannon CP, Klein W, López-Sendón J, Montalescot G, White K, Goldberg RJ. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2003 Oct;24(20):1815-23. doi: 10.1016/s0195-668x(03)00485-8.
Reynolds MR, Josephson ME. MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy. Circulation. 2003 Oct 14;108(15):1779-83. doi: 10.1161/01.CIR.0000086777.82110.F5.
Cutlip DE, Ricciardi MJ, Ling FS, Carrozza JP Jr, Dua V, Garringer J, Giri S, Caputo RP. Effect of tirofiban before primary angioplasty on initial coronary flow and early ST-segment resolution in patients with acute myocardial infarction. Am J Cardiol. 2003 Oct 15;92(8):977-80. doi: 10.1016/s0002-9149(03)00983-4.
Karha J, Murphy SA, Kirtane AJ, de Lemos JA, Aroesty JM, Cannon CP, Antman EM, Braunwald E, Gibson CM; TIMI Study Group. Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction. Am J Cardiol. 2003 Oct 15;92(8):913-8. doi: 10.1016/s0002-9149(03)00969-x.
Turchin A, Seifter JL, Seely EW. Clinical problem-solving. Mind the gap. N Engl J Med. 2003 Oct 9;349(15):1465-9. doi: 10.1056/NEJMcps031078.
Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003 Oct 2;349(14):1315-23. doi: 10.1056/NEJMoa035071.
Gibson CM. Confusion in reperfusion. J Am Coll Cardiol. 2003 Oct 1;42(7):1186-7. doi: 10.1016/s0735-1097(03)00898-2.
Sankoh AJ, D’Agostino RB Sr, Huque MF. Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issues. Stat Med. 2003 Oct 30;22(20):3133-50. doi: 10.1002/sim.1557.
Festa A, Hanley AJ, Tracy RP, D’Agostino R Jr, Haffner SM. Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation. 2003 Oct 14;108(15):1822-30. doi: 10.1161/01.CIR.0000091339.70120.53. Epub 2003 Sep 29.
Haffner SM, D’Agostino R Jr, Festa A, Bergman RN, Mykkänen L, Karter A, Saad MF, Wagenknecht LE. Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?. Diabetes Care. 2003 Oct;26(10):2796-803. doi: 10.2337/diacare.26.10.2796.
Solomon D, Sue Brown A, Brummel-Smith K, Burgess L, D’Agostino RB, Goldschmidt JW, Halter JB, Hazzard WR, Jahnigen DW, Phelps C, Raskind M, Schrier RW, Sox HC, Williams SV, Wykle M. Best paper of the 1980s: National Institutes of Health Consensus Development Conference Statement: geriatric assessment methods for clinical decision-making. 1988. J Am Geriatr Soc. 2003 Oct;51(10):1490-4. doi: 10.1046/j.1532-5415.2003.51471.x.
Serrano CV Jr, Nicolau JC, Venturinelli M, Baracioli LM, Anders RJ, Cannon CP, Ramires JA. Role of oral blockade of platelet glycoprotein IIb/IIIa on neutrophil activation in patients with acute coronary syndromes. Cardiovasc Drugs Ther. 2003 Mar;17(2):129-32. doi: 10.1023/a:1025335718142.
Zimetbaum P, Reynolds MR, Ho KK, Gaziano T, McDonald MJ, McClennen S, Berezin R, Josephson ME, Cohen DJ. Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs. Am J Cardiol. 2003 Sep 15;92(6):677-81. doi: 10.1016/s0002-9149(03)00821-x.
Lloyd-Jones DM, Wilson PW, Larson MG, Leip E, Beiser A, D’Agostino RB, Cleeman JI, Levy D. Lifetime risk of coronary heart disease by cholesterol levels at selected ages. Arch Intern Med. 2003 Sep 8;163(16):1966-72. doi: 10.1001/archinte.163.16.1966.
Suntharalingam M, Laskey WK, Tantibhedhyangkul W, Lansky A, Teirstein P, Bass T, Silber S, Rutherford B, Wilmer C, Popma JJ, Kuntz R, Bonan R. Vascular brachytherapy using a beta emitter source in diabetic patients with in-stent restenosis: angiographic and clinical outcomes. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):536-42. doi: 10.1016/s0360-3016(03)00537-6.
Terrin N, Schmid CH, Griffith JL, D’Agostino RB, Selker HP. External validity of predictive models: a comparison of logistic regression, classification trees, and neural networks. J Clin Epidemiol. 2003 Aug;56(8):721-9. doi: 10.1016/s0895-4356(03)00120-3.
Gibson CM, Gibson WJ, Murphy SA, Marble SJ, McCabe CH, Turakhia MP, Kirtane AJ, Karha J, Aroesty JM, Giugliano RP, Antman EM; TIMI Study Group. Association of the Fibonacci Cascade with the distribution of coronary artery lesions responsible for ST-segment elevation myocardial infarction. Am J Cardiol. 2003 Sep 1;92(5):595-7. doi: 10.1016/s0002-9149(03)00731-8.
Wang TJ, Massaro JM, Levy D, Vasan RS, Wolf PA, D’Agostino RB, Larson MG, Kannel WB, Benjamin EJ. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA. 2003 Aug 27;290(8):1049-56. doi: 10.1001/jama.290.8.1049.
Coskun AU, Yeghiazarians Y, Kinlay S, Clark ME, Ilegbusi OJ, Wahle A, Sonka M, Popma JJ, Kuntz RE, Feldman CL, Stone PH. Reproducibility of coronary lumen, plaque, and vessel wall reconstruction and of endothelial shear stress measurements in vivo in humans. Catheter Cardiovasc Interv. 2003 Sep;60(1):67-78. doi: 10.1002/ccd.10594.
McClennen S, Zimetbaum PJ. Pharmacologic management of atrial fibrillation in the elderly: rate control, rhythm control, and anticoagulation. Curr Cardiol Rep. 2003 Sep;5(5):380-6. doi: 10.1007/s11886-003-0095-z.
Chen EW, Canto JG, Parsons LS, Peterson ED, Littrell KA, Every NR, Gibson CM, Hochman JS, Ohman EM, Cheeks M, Barron HV; Investigators in the National Registry of Myocardial Infarction 2. Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock. Circulation. 2003 Aug 26;108(8):951-7. doi: 10.1161/01.CIR.0000085068.59734.E4. Epub 2003 Aug 11.
Varo N, de Lemos JA, Libby P, Morrow DA, Murphy SA, Nuzzo R, Gibson CM, Cannon CP, Braunwald E, Schönbeck U. Soluble CD40L: risk prediction after acute coronary syndromes. Circulation. 2003 Sep 2;108(9):1049-52. doi: 10.1161/01.CIR.0000088521.04017.13. Epub 2003 Aug 11.
Pinto DS, Ho KK, Zimetbaum PJ, Pedan A, Goldberger AL. Sinus versus nonsinus tachycardia in the emergency department: importance of age and heart rate. BMC Cardiovasc Disord. 2003 Aug 5;3:7. doi: 10.1186/1471-2261-3-7. Epub 2003 Aug 5.
Gibson CM. Has my patient achieved adequate myocardial reperfusion?. Circulation. 2003 Aug 5;108(5):504-7. doi: 10.1161/01.CIR.0000082932.69023.74.
Sperling RT, Pinto DS, Ho KK, Carrozza JP Jr. Platelet glycoprotein IIb/IIIa inhibition with eptifibatide: prolongation of inhibition of aggregation in acute renal failure and reversal with hemodialysis. Catheter Cardiovasc Interv. 2003 Aug;59(4):459-62. doi: 10.1002/ccd.10576.
Caputo RP, Flately M, Ho KK, Baim DS. Safety and effectiveness of stent implantation without predilation for small coronary arteries. Catheter Cardiovasc Interv. 2003 Aug;59(4):455-8. doi: 10.1002/ccd.10581.
Cannon CP. Elderly patients with acute coronary syndromes: higher risk and greater benefit from antiplatelet therapy and/or interventional therapies. Am J Geriatr Cardiol. 2003 Jul-Aug;12(4):259-62. doi: 10.1111/j.1076-7460.2003.02012.x.
Marrugat J, D’Agostino R, Sullivan L, Elosua R, Wilson P, Ordovas J, Solanas P, Cordón F, Ramos R, Sala J, Masiá R, Kannel WB. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health. 2003 Aug;57(8):634-8. doi: 10.1136/jech.57.8.634.
Meigs JB, Wilson PW, Nathan DM, D’Agostino RB Sr, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes. 2003 Aug;52(8):2160-7. doi: 10.2337/diabetes.52.8.2160.
Morrow DA, Rifai N, Sabatine MS, Ayanian S, Murphy SA, de Lemos JA, Braunwald E, Cannon CP. Evaluation of the AccuTnI cardiac troponin I assay for risk assessment in acute coronary syndromes. Clin Chem. 2003 Aug;49(8):1396-8. doi: 10.1373/49.8.1396.
Yang Q, Tofler GH, Cupples LA, Larson MG, Feng D, Lindpaintner K, Levy D, D’Agostino RB, O’Donnell CJ. A genome-wide search for genes affecting circulating fibrinogen levels in the Framingham Heart Study. Thromb Res. 2003 Apr 15;110(1):57-64. doi: 10.1016/s0049-3848(03)00288-3.
Stone GW, Rogers C, Hermiller J, Feldman R, Hall P, Haber R, Masud A, Cambier P, Caputo RP, Turco M, Kovach R, Brodie B, Herrmann HC, Kuntz RE, Popma JJ, Ramee S, Cox DA; FilterWire EX Randomized Evaluation Investigators. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation. 2003 Aug 5;108(5):548-53. doi: 10.1161/01.CIR.0000080894.51311.0A. Epub 2003 Jul 21.
Wang TJ, Nam BH, D’Agostino RB, Wolf PA, Lloyd-Jones DM, MacRae CA, Wilson PW, Polak JF, O’Donnell CJ. Carotid intima-media thickness is associated with premature parental coronary heart disease: the Framingham Heart Study. Circulation. 2003 Aug 5;108(5):572-6. doi: 10.1161/01.CIR.0000081764.35431.DE. Epub 2003 Jul 21.
Stone PH, Coskun AU, Kinlay S, Clark ME, Sonka M, Wahle A, Ilegbusi OJ, Yeghiazarians Y, Popma JJ, Orav J, Kuntz RE, Feldman CL. Effect of endothelial shear stress on the progression of coronary artery disease, vascular remodeling, and in-stent restenosis in humans: in vivo 6-month follow-up study. Circulation. 2003 Jul 29;108(4):438-44. doi: 10.1161/01.CIR.0000080882.35274.AD. Epub 2003 Jul 14.
Aepfelbacher FC, Yeon SB, Ho KK, Parker JA, Danias PG. ECG-gated 99mTc single-photon emission CT for assessment of right ventricular structure and function: is the information provided similar to echocardiography?. Chest. 2003 Jul;124(1):227-32. doi: 10.1378/chest.124.1.227.
Murphy SA, Dauterman K, de Lemos JA, Kermgard S, Antman EM, Braunwald E, Gibson CM; Thrombolysis In Myocardial Infarction 14 Investigators. Angiographic and clinical characteristics associated with the development of Q-wave and non-Q-wave myocardial infarction in the thrombolysis in myocardial infarction (TIMI) 14 trial. Am Heart J. 2003 Jul;146(1):42-7. doi: 10.1016/S0002-8703(03)00145-5.
Gibson CM, Karha J, Murphy SA, James D, Morrow DA, Cannon CP, Giugliano RP, Antman EM, Braunwald E; TIMI Study Group. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials. J Am Coll Cardiol. 2003 Jul 2;42(1):7-16. doi: 10.1016/s0735-1097(03)00506-0.
Chen HS, Pinto DS. Images in clinical medicine. Prinzmetal’s angina. N Engl J Med. 2003 Jul 3;349(1):e1. doi: 10.1056/ENEJMicm020631.
Murphy SA, Gibson CM. Diminution in flow following primary stenting in the INAMI study. Catheter Cardiovasc Interv. 2003 Jul;59(3):417; author reply 417-8. doi: 10.1002/ccd.10591.
Hauser TH, Pinto DS, Josephson ME, Zimetbaum P. Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter. Am J Cardiol. 2003 Jun 15;91(12):1437-41. doi: 10.1016/s0002-9149(03)00395-3.
Cannon CP, Turpie AG. Unstable angina and non-ST-elevation myocardial infarction: initial antithrombotic therapy and early invasive strategy. Circulation. 2003 Jun 3;107(21):2640-5. doi: 10.1161/01.CIR.0000072246.69344.2D.
Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D’Agostino RB, Murabito JM, Kannel WB, Benjamin EJ. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003 Jun 17;107(23):2920-5. doi: 10.1161/01.CIR.0000072767.89944.6E. Epub 2003 May 27.
Tcheng JE, Madan M, O’Shea JC, Cohen EA, Buller CE, Lincoff AM, Popma JJ, Teirstein PS, Kitt MM, Lorenz TJ, Greenberg S, Fost N, Califf RM. Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention. J Interv Cardiol. 2003 Apr;16(2):97-105. doi: 10.1046/j.1540-8183.2003.08020.x.
Mauri L, Reisman M, Buchbinder M, Popma JJ, Sharma SK, Cutlip DE, Ho KK, Prpic R, Zimetbaum PJ, Kuntz RE. Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries: results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART). Am Heart J. 2003 May;145(5):847-54. doi: 10.1016/S0002-8703(03)00080-2.
Wong GC, Frisch D, Murphy SA, Sabatine MS, Pai R, James D, Kraimer N, Katsiyiannis PT, Marble SJ, DiBattiste PM, Demopoulos LA, Gourlay SG, Barron HV, Cannon CP, Gibson CM; LIMIT AMI and TACTICS-TIMI 18 Study Groups. Time for contrast material to traverse the epicardial artery and the myocardium in ST-segment elevation acute myocardial infarction versus unstable angina pectoris/non-ST-elevation acute myocardial infarction. Am J Cardiol. 2003 May 15;91(10):1163-7. doi: 10.1016/s0002-9149(03)00260-1.
Tan ZS, Seshadri S, Beiser A, Wilson PW, Kiel DP, Tocco M, D’Agostino RB, Wolf PA. Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Intern Med. 2003 May 12;163(9):1053-7. doi: 10.1001/archinte.163.9.1053.
Guerra DR, Karha J, Gibson CM. Safety and efficacy of tenecteplase in acute myocardial infarction. Expert Opin Pharmacother. 2003 May;4(5):791-8. doi: 10.1517/14656566.4.5.791.
Singh M, Rosenschein U, Ho KK, Berger PB, Kuntz R, Holmes DR Jr. Treatment of saphenous vein bypass grafts with ultrasound thrombolysis: a randomized study (ATLAS). Circulation. 2003 May 13;107(18):2331-6. doi: 10.1161/01.CIR.0000066693.22220.30. Epub 2003 May 5.
Festa A, D’Agostino R Jr, Rich SS, Jenny NS, Tracy RP, Haffner SM. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Circulation. 2003 May 20;107(19):2422-7. doi: 10.1161/01.CIR.0000066908.82782.3A. Epub 2003 Apr 28.
McClennen S, Halamka JD, Horowitz GL, Kannam JP, Ho KK. Clinical prevalence and ramifications of false-positive cardiac troponin I elevations from the Abbott AxSYM Analyzer. Am J Cardiol. 2003 May 1;91(9):1125-7. doi: 10.1016/s0002-9149(03)00164-4.
Dotani MI, Morise AP, Haque R, Jain AC, Gupta N, Gibson CM. Association between short-term simvastatin therapy before coronary artery bypass grafting and postoperative myocardial blood flow as assessed by positron emission tomography. Am J Cardiol. 2003 May 1;91(9):1107-9. doi: 10.1016/s0002-9149(03)00158-9.
Giugliano GR, Giugliano RP, Gibson CM, Kuntz RE. Meta-analysis of corticosteroid treatment in acute myocardial infarction. Am J Cardiol. 2003 May 1;91(9):1055-9. doi: 10.1016/s0002-9149(03)00148-6.
Morrow DA, de Lemos JA, Sabatine MS, Murphy SA, Demopoulos LA, DiBattiste PM, McCabe CH, Gibson CM, Cannon CP, Braunwald E. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol. 2003 Apr 16;41(8):1264-72. doi: 10.1016/s0735-1097(03)00168-2.
Giugliano RP, Roe MT, Harrington RA, Gibson CM, Zeymer U, Van de Werf F, Baran KW, Hobbach HP, Woodlief LH, Hannan KL, Greenberg S, Miller J, Kitt MM, Strony J, McCabe CH, Braunwald E, Califf RM; INTEGRITI Investigators. Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial. J Am Coll Cardiol. 2003 Apr 16;41(8):1251-60. doi: 10.1016/s0735-1097(03)00123-2.
McDermott DH, Fong AM, Yang Q, Sechler JM, Cupples LA, Merrell MN, Wilson PW, D’Agostino RB, O’Donnell CJ, Patel DD, Murphy PM. Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J Clin Invest. 2003 Apr;111(8):1241-50. doi: 10.1172/JCI16790.
D’Agostino R, Melagrana A, Taborelli G. Benign positional paroxysmal vertigo of horizontal semicircular canal in the child: case report. Int J Pediatr Otorhinolaryngol. 2003 May;67(5):549-51. doi: 10.1016/s0165-5876(03)00009-0.
Sullivan LM, D’Agostino RB Sr. Robustness and power of analysis of covariance applied to ordinal scaled data as arising in randomized controlled trials. Stat Med. 2003 Apr 30;22(8):1317-34. doi: 10.1002/sim.1433.
Pinto DS, Lorenz DP, Murphy SA, Marble SJ, DiBattiste PM, Demopoulos LA, Cannon CP, Gibson CM; TIMI Study Group. Association of an activated clotting time < or =250 seconds with adverse event rates after percutaneous coronary intervention using tirofiban and heparin (a TACTICS-TIMI 18 substudy). Am J Cardiol. 2003 Apr 15;91(8):976-8, A4. doi: 10.1016/s0002-9149(03)00117-6.
Cotter G, Cannon CP, McCabe CH, Michowitz Y, Kaluski E, Charlesworth A, Milo O, Bentley J, Blatt A, Krakover R, Zimlichman R, Reisin L, Marmor A, Lewis B, Vered Z, Caspi A, Braunwald E; OPUS-TIMI 16 Investigators. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study. Am Heart J. 2003 Apr;145(4):622-7. doi: 10.1067/mhj.2003.6.
Sanders GP, Pinto DS, Parker JA, Koutkia P, Aepfelbacher FC, Danias PG. Increased resting Tl-201 lung-to-heart ratio is associated with invasively determined measures of left ventricular dysfunction, extent of coronary artery disease, and resting myocardial perfusion abnormalities. J Nucl Cardiol. 2003 Mar-Apr;10(2):140-7. doi: 10.1067/mnc.2003.399.
Elmariah S, Gunn RB. Kinetic evidence that the Na-PO4 cotransporter is the molecular mechanism for Na/Li exchange in human red blood cells. Am J Physiol Cell Physiol. 2003 Aug;285(2):C446-56. doi: 10.1152/ajpcell.00606.2002. Epub 2003 Apr 2.
Singh G, Miller JD, Huse DM, Pettitt D, D’Agostino RB, Russell MW. Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis. J Rheumatol. 2003 Apr;30(4):714-9.
Fox CS, Vasan RS, Parise H, Levy D, O’Donnell CJ, D’Agostino RB, Benjamin EJ; Framingham Heart Study. Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study. Circulation. 2003 Mar 25;107(11):1492-6. doi: 10.1161/01.cir.0000058168.26163.bc.
Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, Levy D, Wilson PW, D’Agostino RB; Framingham Heart Study. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation. 2003 Mar 25;107(11):1486-91. doi: 10.1161/01.cir.0000057810.48709.f6.
Stone GW, Cox DA, Low R, Cates CU, Satler L, Bailey SR, Kuntz RE, Lansky AJ; X-TRACT Investigators. Safety and efficacy of a novel device for treatment of thrombotic and atherosclerotic lesions in native coronary arteries and saphenous vein grafts: results from the multicenter X-Sizer for treatment of thrombus and atherosclerosis in coronary applications trial (X-TRACT) study. Catheter Cardiovasc Interv. 2003 Apr;58(4):419-27. doi: 10.1002/ccd.10511.
Hadigan C, Meigs JB, Wilson PW, D’Agostino RB, Davis B, Basgoz N, Sax PE, Grinspoon S. Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution. Clin Infect Dis. 2003 Apr 1;36(7):909-16. doi: 10.1086/368185. Epub 2003 Mar 20.
Cannon CP. Small molecule glycoprotein IIb/IIIa receptor inhibitors as upstream therapy in acute coronary syndromes: insights from the TACTICS TIMI-18 trial. J Am Coll Cardiol. 2003 Feb 19;41(4 Suppl S):43S-48S. doi: 10.1016/s0735-1097(02)03018-8.
Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, Shah PK, Willerson JT, Benza RL, Berman DS, Gibson CM, Bajamonde A, Rundle AC, Fine J, McCluskey ER; VIVA Investigators. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation. 2003 Mar 18;107(10):1359-65. doi: 10.1161/01.cir.0000061911.47710.8a.
Vasan RS, Beiser A, D’Agostino RB, Levy D, Selhub J, Jacques PF, Rosenberg IH, Wilson PW. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. JAMA. 2003 Mar 12;289(10):1251-7. doi: 10.1001/jama.289.10.1251.
Hiller R, Sperduto RD, Reed GF, D’Agostino RB, Wilson PW. Serum lipids and age-related lens opacities: a longitudinal investigation: the Framingham Studies. Ophthalmology. 2003 Mar;110(3):578-83. doi: 10.1016/S0161-6420(02)01762-1.
Marrugat J, Solanas P, D’Agostino R, Sullivan L, Ordovas J, Cordón F, Ramos R, Sala J, Masià R, Rohlfs I, Elosua R, Kannel WB. [Coronary risk estimation in Spain using a calibrated Framingham function]. Rev Esp Cardiol. 2003 Mar;56(3):253-61. doi: 10.1016/s0300-8932(03)76861-4.
Zimetbaum PJ, Josephson ME. Use of the electrocardiogram in acute myocardial infarction. N Engl J Med. 2003 Mar 6;348(10):933-40. doi: 10.1056/NEJMra022700.
Reynolds MR, Neil N, Ho KK, Berezin R, Cosgrove RS, Lager RA, Sirois C, Johnson RG, Cohen DJ. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience. Am Heart J. 2003 Feb;145(2):334-42. doi: 10.1067/mhj.2003.38.
Bass TA, Gilmore P, Zenni M, Sasseen B, Savage M, Bonan R, Laskey W, Popma JJ, Costa MA. Debulking does not benefit patients undergoing intracoronary beta-radiation therapy for in-stent restenosis: insights from the START trial. Catheter Cardiovasc Interv. 2003 Mar;58(3):331-5. doi: 10.1002/ccd.10436.
Elias MF, Elias PK, Sullivan LM, Wolf PA, D’Agostino RB. Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord. 2003 Feb;27(2):260-8. doi: 10.1038/sj.ijo.802225.
Januzzi JL Jr, Sabatine MS, Wan Y, Servoss SJ, DiBattiste PM, Jang Ik, Theroux P. Interactions between age, outcome of acute coronary syndromes, and tirofiban therapy. Am J Cardiol. 2003 Feb 15;91(4):457-61. doi: 10.1016/s0002-9149(02)03247-2.
de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, McCabe CH, Cannon CP, Braunwald E. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation. 2003 Feb 11;107(5):690-5. doi: 10.1161/01.cir.0000049742.68848.99.
Murphy SA, Chen C, Gourlay SG, Gibbons RJ, Barron HV, Gibson CM; Limitation of Myocardial Infarction following Thrombolysis in Acute Myocardial Infarction Study Group. Impairment of myocardial perfusion in both culprit and nonculprit arteries in acute myocardial infarction: a LIMIT AMI substudy. Am J Cardiol. 2003 Feb 1;91(3):325-8. doi: 10.1016/s0002-9149(02)03160-0.
Selker HP, Raitt MH, Schmid CH, Laks MM, Beshansky JR, Griffith JL, Califf RM, Selvester RH, Maynard C, D’Agostino RB, Weaver WD. Time-dependent predictors of primary cardiac arrest in patients with acute myocardial infarction. Am J Cardiol. 2003 Feb 1;91(3):280-6. doi: 10.1016/s0002-9149(02)03155-7.
Binder EF, Kruse RL, Sherman AK, Madsen R, Zweig SC, D’Agostino R, Mehr DR. Predictors of short-term functional decline in survivors of nursing home-acquired lower respiratory tract infection. J Gerontol A Biol Sci Med Sci. 2003 Jan;58(1):60-7. doi: 10.1093/gerona/58.1.m60.
Sousa JE, Costa MA, Sousa AG, Abizaid AC, Seixas AC, Abizaid AS, Feres F, Mattos LA, Falotico R, Jaeger J, Popma JJ, Serruys PW. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation. 2003 Jan 28;107(3):381-3. doi: 10.1161/01.cir.0000051720.59095.6d.
Degertekin M, Regar E, Tanabe K, Smits PC, van der Giessen WJ, Carlier SG, de Feyter P, Vos J, Foley DP, Ligthart JM, Popma JJ, Serruys PW. Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience. J Am Coll Cardiol. 2003 Jan 15;41(2):184-9. doi: 10.1016/s0735-1097(02)02704-3.
O’Malley AJ, Normand SL, Kuntz RE. Application of models for multivariate mixed outcomes to medical device trials: coronary artery stenting. Stat Med. 2003 Jan 30;22(2):313-36. doi: 10.1002/sim.1337.
D’Agostino RB Sr, Massaro JM, Sullivan LM. Non-inferiority trials: design concepts and issues – the encounters of academic consultants in statistics. Stat Med. 2003 Jan 30;22(2):169-86. doi: 10.1002/sim.1425.
Sousa JE, Costa MA, Abizaid A, Sousa AG, Feres F, Mattos LA, Centemero M, Maldonado G, Abizaid AS, Pinto I, Falotico R, Jaeger J, Popma JJ, Serruys PW. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation. 2003 Jan 7;107(1):24-7. doi: 10.1161/01.cir.0000047063.22006.41.
Bahit MC, Cannon CP, Antman EM, Murphy SA, Gibson CM, McCabe CH, Braunwald E; TIMI 9 Trial and TIMI 9 Registry. Thrombolysis In Myocardial Infarction. Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry. Am Heart J. 2003 Jan;145(1):109-17. doi: 10.1067/mhj.2003.43.
Resnic FS, Wainstein M, Lee MK, Behrendt D, Wainstein RV, Ohno-Machado L, Kirshenbaum JM, Rogers CD, Popma JJ, Piana R. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J. 2003 Jan;145(1):42-6. doi: 10.1067/mhj.2003.36.
Pinto DS, Sperling RT, Tu TM, Cohen DJ, Carrozza JP Jr. Combination platelet glycoprotein IIb/IIIa receptor and lepirudin administration during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia. Catheter Cardiovasc Interv. 2003 Jan;58(1):65-8. doi: 10.1002/ccd.10393.
Silva JA, White CJ, Ramee SR, Collins TJ, Jenkins JS, Ho K, Baim DS, Carrozza JP, Rinfret S, Setum CM, Popma JJ, Kuntz RE. Treatment of coronary stent thrombosis with rheolytic thrombectomy: results from a multicenter experience. Catheter Cardiovasc Interv. 2003 Jan;58(1):11-7. doi: 10.1002/ccd.10385.
Zimetbaum P, Ho KK, Olshansky B, Hadjis T, Lemery R, Friedman PA, Cannom DS, Chen XH, Josephson ME; FRACTAL Investigators. Variation in the utilization of antiarrhythmic drugs in patients with new-onset atrial fibrillation. Am J Cardiol. 2003 Jan 1;91(1):81-3. doi: 10.1016/s0002-9149(02)03004-7.